Risk of brain clots higher with COVID than vaccine, study suggestsA study has suggested that the risk of getting a serious brain clot is eight to 10 times Share XRisk of brain clots higher with COVID than vaccine, study suggestshttps://pharmaphorum.com/news/risk-of-brain-clots-higher-with-covid-than-vaccine-study-suggests/
NICE recommends Alexion’s long-acting Ultomiris for PNHNICE has recommended Alexion’s long-acting Ultomiris (ravulizumab) for the rare disease paroxysmal nocturnal haemoglobinuria (PNH) in final draft Share XNICE recommends Alexion’s long-acting Ultomiris for PNHhttps://pharmaphorum.com/news/nice-recommends-alexions-long-acting-ultomiris-for-pnh/
Czech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotsThe Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, Share XCzech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotshttps://pharmaphorum.com/news/czech-republic-swoops-for-denmarks-2-4m-unwanted-az-covid-shots/
AZ aims at Pfizer, GSK with potential new PARP cancer drugAstraZeneca’s Lynparza (olaparib) blazed a trail for the new class of PARP drugs when it was approved in Share XAZ aims at Pfizer, GSK with potential new PARP cancer drughttps://pharmaphorum.com/news/az-aims-at-pfizer-gsk-with-potential-new-parp-cancer-drug/
AstraZeneca’s Farxiga fails phase 3 COVID-19 testHope that AstraZeneca’s diabetes and heart failure drug Farxiga might treat patients hospitalised with COVID-19 have been dashed Share XAstraZeneca’s Farxiga fails phase 3 COVID-19 testhttps://pharmaphorum.com/news/astrazenecas-farxiga-fails-phase-3-covid-19-test/
UK will offer under-30s alternative to AZ’s COVID jabThe UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZeneca Share XUK will offer under-30s alternative to AZ’s COVID jabhttps://pharmaphorum.com/news/uk-will-offer-under-30s-alternative-to-azs-covid-jab/
Paediatric trial of AZ COVID jab ‘halted as a precaution’Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a Share XPaediatric trial of AZ COVID jab ‘halted as a precaution’https://pharmaphorum.com/news/paediatric-trial-of-az-covid-jab-halted-as-a-precaution/
Could Moderna shot save UK’s under-50s COVID vaccination push?People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according Share XCould Moderna shot save UK’s under-50s COVID vaccination push?https://pharmaphorum.com/news/could-moderna-shot-save-uks-under-50s-covid-vaccination-push/
AZ exits US vaccine plant after mix-up spoils J&J’s COVID jabAstraZeneca is shifting production of its COVID-19 vaccine away from a plant in Baltimore which also makes Johnson Share XAZ exits US vaccine plant after mix-up spoils J&J’s COVID jabhttps://pharmaphorum.com/news/az-exits-us-vaccine-plant-after-mix-up-spoils-jjs-covid-jab/
